Alexion, AstraZeneca Rare Disease

121 Seaport Blvd
Boston,  MA  02210

United States
http://Alexion.com
  • Booth: 2808

Alexion is a global biopharmaceutical company that focuses on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes the first and only approved complement inhibitor to treat patients with PNH and aHUS. In addition, Alexion’s metabolic franchise includes two highly innovative enzyme replacement therapies.

Categories

PRODUCT AND SERVICES
  • Biologicals
    • COMPANY TYPE
  • Pharmaceuticals
    • Back to the Search
    Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined
     
    Reserve a Booth Exhibitor Login Sponsor ASH News TV

    Have a Question?
    Call 888-273-5704

    International callers dial
    001 703-449-6418

    Monday - Friday
    9 a.m. - 5 p.m.
    Eastern Time

    Contact us
      • ASH Exposition Management
      • SPARGO, Inc.
      • Toll Free: (800) 564-4220
      • Phone: (703) 631-6200
      • Fax: (703) 563-2691
      • Email: ashexhibits@spargoinc.com